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Abstract  
A linear encoder measuring vertical displacement during the heel-rise endurance test (HRET) 
enables the assessment of work and maximum height in addition to the traditional repetitions 
measure.  We aimed to compare the test-retest reliability and agreement of these three outcome 
measures. Thirty-eight healthy participants (20 females, 18 males) performed the HRET on 
two occasions separated by a minimum of seven days. Reliability was assessed by the intraclass 
correlation coefficient (ICC) and agreement by a range of measures including the standard error 
of measurement (SEM), coefficient of variation (CV), and 95% limits of agreement (LoA). 
Reliability for repetitions (ICC = 0.77 (0.66, 0.85)) was equivalent to work (ICC = 0.84 (95% 
CI 0.76, 0.89)) and maximum height (ICC = 0.85 (0.77, 0.90)). Agreement for repetitions (SEM 
= 6.7 (5.8, 7.9); CV = 13.9% (11.9, 16.8%); LoA = -1.9 ± 37.2%) was equivalent to work (SEM 
= 419 J (361, 499 J); CV = 13.1% (11.2, 15.8%); LoA = 0.1 ± 34.8%) with maximum height 
superior (SEM = 0.8 cm (0.6, 1.0 cm); CV = 6.6% (5.7, 7.9%); LoA = 1.3 ± 17.1%). Work and 
maximum height demonstrated acceptable reliability and agreement that was at least equivalent 
to the traditional repetitions measure. 
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Introduction 
The heel rise endurance test (HRET) is a popular method of assessing ankle function in research 
and clinical practice (Hebert-Losier et al., 2009a, Hebert-Losier et al., 2009b). The HRET 
involves repetitive concentric-eccentric muscle action of the plantar flexors in unipedal stance 
until volitional task failure with a side-to-side comparison of the maximum number of 
repetitions defining the outcome measure (Hebert-Losier et al., 2009a). Maximum repetitions 
demonstrates acceptable test-retest reliability and agreement (Moller et al., 2005) and is 
consistently employed as an outcome measure in rehabilitation studies of Achilles tendon 
rupture (ATR) (Bostick et al., 2010, Buchgraber and Passler, 1997, Moller et al., 2002, Weber 
et al., 2003).  
Silbernagel et al. (Silbernagel et al., 2006, Silbernagel et al., 2010) recently introduced 
a new HRET measuring device in the form of a linear displacement sensor attached to the heel 
enabling the height of each repetition to be measured and three outcome measures quantified 
i.e. number of repetitions, total work in joules, and maximum heel rise height in cm. The 
authors reported that the two novel outcome measures of work and maximum height were more 
sensitive than repetitions in detecting functional impairment at 6, 12, and 24 months following 
ATR and recommended their use as outcome measures in future research (Silbernagel et al., 
2010, Olsson et al., 2011). Whilst work and maximum height have demonstrated good criterion 
validity and responsiveness (Silbernagel et al., 2010, Nilsson-Helander et al., 2010, Olsson et 
al., 2011), the measurement properties of reliability and agreement for these two novel indices 
have yet to be determined in either healthy or clinical populations. Our purpose was to evaluate 
these measurement properties, firstly in healthy participants, with a view to employing the 
HRET as the primary outcome measure in a large multi-centre randomised controlled trial 
comparing treatment with platelet-rich plasma injection versus placebo in acute Achilles 
tendon rupture (PATH-2 Trial, ClinicalTrials.gov registration number NCT02302664).     
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Therefore, the aim of the current study was to measure and compare the intrarater test-
retest reliability and measurement agreement of the three HRET outcome measures in healthy 
adult participants during a standardised and computerised HRET employing a linear 
displacement sensor. The findings are reported in accordance with recent guidelines for 
reporting reliability and agreement studies (Kottner et al., 2011).       
 
Methods  
Participants 
Participants were recruited through advertisement posters on University research community 
notice boards.  Inclusion criteria were age 18 years and above, able to give informed consent 
and follow instructions. Exclusion criteria were history (in either leg) of Achilles tendon pain, 
previous Achilles tendon rupture, previous major ankle injury or deformity, and recent lower 
limb injury. Forty healthy participants (20 males & 20 females) volunteered with written 
informed consent to participate in this study, which was approved by the Institutional ethics 
committee. Data are presented on 38 participants (18 males & 20 females; mean ± SD age 36 
± 9 years, body mass 71.5 ± 15.3 kg) because two participants withdrew from the study 
following the first test. 
 
Heel-Rise Endurance Test 
To evaluate test-retest reliability and agreement, the HRET was performed on two separate 
occasions separated by an interval of at least seven days. Since this form of exercise has a large 
eccentric component and is unaccustomed for most people it often produces the symptoms of 
exercise-induced muscle damage (e.g. muscle weakness and delayed-onset muscle soreness) 
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and therefore a minimum seven-day recovery period was chosen to allow full recovery between 
the test and retest (Byrne et al., 2004). To determine the intrarater reliability and agreement of 
the procedures in our own hands (Weir, 2005), a single trained outcome assessor performed all 
HRET measurements and was therefore an unblinded assessor. Participants were instructed to 
maintain their normal levels of physical activity between tests and to avoid any intense physical 
activity in the hours before testing. Before testing, participants completed the Lower Extremity 
Functional Scale (scored from 0-80 with higher scores indicating better function) (Binkley et 
al., 1999), had their body mass measured on calibrated class III scales, watched  a video 
demonstration of the HRET, read standardised written instructions detailing their expected 
conduct during the test, and completed a standardised warm-up. The warm-up consisted of five 
minutes continuous walking at usual pace followed by 10 double leg heel rises on a 10° incline 
box guided by a digital metronome at a rate of 30 heel rises·min-1.  
During the test, participants were instructed to adopt a single leg stance with full knee 
extension on a 10° incline box facing a wall with only fingertip support; to raise the heel as 
high as possible on each repetition at a rate of 30 rises·min-1 guided by a digital metronome; 
and to perform as many heel raises as possible (Hebert-Losier et al., 2009a, Silbernagel et al., 
2010). The dominant limb was tested first and then the non-dominant limb after three minutes 
of recovery. The height of each heel-rise was measured by a spring-loaded cord attached to the 
bare heel of the participant and connected to a linear displacement sensor with a measurement 
resolution and sample rate of 0.019 mm and 200 Hz, respectively (Encoder, MUSCLELAB™, 
Ergotest Innovation A.S., Porsgrunn, Norway). Each test was video recorded and a bespoke 
software integrated encoder and video data (PATH-2, MUSCLELAB™, Ergotest Innovation 
A.S., Porsgrunn, Norway). Figure 1 illustrates the experimental set-up. The software was 
programmed with 1.0 cm concentric (upward) and eccentric (downward) thresholds to provide 
tolerance for minor movements and signal directional changes (eccentric ≥1.0 cm) and new 
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repetitions (concentric ≥1.0 cm). Participants either stopped (i.e. volitional task failure) or were 
audibly instructed to stop with both feet flat on the box whenever any of the following test 
termination criteria were observed: inability to keep pace with the metronome; inability to 
maintain full knee extension of the standing leg; or using more than fingertip support. The 
desired endpoint was volitional task failure, however the outcome assessor used verbal prompts 
whenever the termination criteria were observed and stopped the test if the participant did not 
respond to two consecutive prompts.  
 
**** Insert Figure 1 Here **** 
 
Data Processing 
Displacement and video data were reviewed after each HRET to identify and eliminate any 
movement artefacts from the data that occurred after test termination but before the linear 
encoder had stopped recording data. Large amplitude movement artefacts (mean ± SD height 
= 29.6 ± 9.0 cm) were observed and removed in 4.6% of tests due to participants moving their 
leg to alleviate discomfort immediately after test termination. For comparison to previous 
research, only repetitions with height ≥5.0 cm were included in the analysis (Moller et al., 
2005, Svantesson et al., 1998). Repetitions <5.0 cm were observed in 31.6% of tests resulting 
in a (mean ± SD) minor loss of 1.8 ± 0.9 (range 1-5) repetitions per affected test. These 
repetitions were removed from individual datasets during the post-HRET data and video 
review. Additionally, two consecutive repetitions <5.0 cm was considered a final test 
termination criteria in the post-HRET data and video review and was observed in 11.2% of 
tests (Buchgraber and Passler, 1997). Three HRET outcome measures were defined as: number 
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of repetitions (n); work (J) as the product of body mass (kg), total vertical displacement (m), 
and the constant 9.807 converting kilopond-metres to joules; and maximum height (cm) as the 
greatest height of a single repetition (Silbernagel et al., 2010). Additionally, a limb symmetry 
index was computed for each measure as the performance of the left leg as a percentage of the 
right leg (Silbernagel et al., 2010).     
 
Statistical Analysis 
A number of statistical methods for assessing measurement error were employed (Kottner et 
al., 2011). Descriptive data are presented as mean and standard deviation. Evidence of test-
retest systematic bias was analysed with paired sample t-tests to investigate changes in the 
mean. The mean differences are presented with the 95% confidence interval (95% CI), and the 
standardized mean difference effect size (d) was calculated and interpreted as: trivial (<0.2); 
small (≥0.2); medium (≥0.5); or large (≥0.8). The intraclass correlation coefficient (ICC) type 
2,1 (two-way random, consistency definition) with 95% CI examined intrarater reliability as 
the relative consistency of individuals across days (Weir, 2005). Measurement agreement (i.e. 
the degree to which scores are identical) was examined with four methods. Firstly, the standard 
error of measurement (SEM) with 95% CI described the variation in the same units as the 
original measurement (Weir, 2005, Hopkins, 2000). Secondly, following logarithmic (natural) 
transformation of the data, the coefficient of variation (CV) with 95% CI described the 
variation in percent (Hopkins, 2000). Thirdly, the minimal detectable change at the 90% 
confidence level (MDC90) was computed to estimate values representing a meaningful and true 
change (Weir, 2005). Finally, 95% limits of agreement (LoA) were expressed in original 
measurement units and as percent differences (Bland and Altman, 1986). During LoA analysis, 
Pearson’s correlation coefficient (r) was employed to determine if absolute differences were 
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proportional to the magnitude of measurement (i.e. heteroscedasticity). If heteroscedasticity 
was still present (i.e. P < 0.05) after expressing absolute differences as a percentage of the 
individual mean values, a logarithmic (natural) transformation of the original data was 
performed followed by antilogs to express the LoA as ratio percentages (Bland and Altman, 
1986). Statistical analysis was performed with IBM SPSS Statistics 23.     
 
Results 
The 38 participants completed the study with a test-retest interval of 9 ± 2 (range 7-14) days. 
No changes in body mass (test = 71.5 ± 15.5 kg; retest = 71.5 ± 15.4 kg, P = 0.745) or LEFS 
(test = 78.5 ± 4.4; retest = 78.7 ± 4.3, P = 0.071) were observed. Table 1 illustrates that no 
significant test-retest changes in the mean were observed for each outcome measure with all 
effect sizes being trivial. Table 2 illustrates reliability and agreement data for each outcome 
measure. Heteroscedasticity was observed in repetitions and work LoA data. Expressing LoA 
as percentages resolved the issue for work but not repetitions. Logarithmic transformation and 
expression as ratio LoA also failed to resolve the heteroscedasticity issue for repetitions. Figure 
2 illustrates LoA absolute and percent differences plots for the three outcome measures.  
 
**** Insert Table 1 Here **** 
**** Insert Table 2 Here **** 
**** Insert Figure 2 Here **** 
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Fatigue was evident during the tests, as illustrated by the 5.8 ± 2.2 (1.5-12.0) cm or 42.3 ± 
13.9 (12.0-69.0) % reduction from maximum to minimum repetition height. Maximum height 
(13.6 cm) occurred on average on the 4th repetition (12% of total) with minimum height (7.8 
cm) occurring on the 32nd repetition (93% of total). 
 
Discussion 
With healthy adult participants, a standardised protocol, and a single outcome assessor, the 
novel HRET outcome measures of work and maximum height demonstrated acceptable 
reliability and measurement agreement that was at least equivalent to the traditional repetitions 
measure. No evidence of systematic bias was observed for the three measures on each limb 
suggesting the absence of any learning effect on performance. ICC, representing the test-retest 
relative consistency of individuals was good (i.e. >0.7) for all measures (de Vet et al., 2006). 
Although ICC estimates for work (ICC = 0.84 (0.76 to 0.89)) and maximum height (ICC = 0.85 
(0.77 to 0.90)) appeared better than repetitions (ICC = 0.77 (0.66 to 0.85)), we interpreted 
reliability as equivalent between the three measures due to the overlap in 95% CI. ICC for limb 
symmetry indices was understandably poor due to the low range of values in our healthy 
participants (de Vet et al., 2006).  
The SEM and CV agreement data in Table 2 indicate the typical error expected from 
test to test for any one participant (Hopkins, 2000). It is expected that 68% of differences 
between tests will lie within the SEM or CV. The CV for repetitions (13.9% (11.9, 16.8%)) 
was equivalent to work (13.1% (11.2, 15.8) with maximum height (6.6% (5.7, 7.9%)) 
demonstrating superior agreement than both repetitions and work. The MDC90 data in Table 2 
indicate that 90% of individuals will demonstrate variation less than this magnitude when 
retested and that a true change in performance is one that exceeds the MDC90 value (Weir, 
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2005). The 95% LoA results illustrated in Figure 2 and Table 2 confirm the absence of 
systematic bias for all measures and indicate that for a new individual from the studied 
population, it would be expected with 95% probability, that test-retest differences would fall 
within the LoA (Bland and Altman, 1986). Measurement error was proportional to the mean 
for repetitions and work, and although percent LoA resolved this issue for work, 
heteroscedasticity remained for repetitions even after logarithmic transformation of the data 
(Bland and Altman, 1986). As illustrated in Figure 2 (B, D, F), percent LoA revealed that 
random error for maximum height (± 17.1%) was less than half that of work (± 34.8%) and 
repetitions (± 37.2%). In summary, measurement agreement for repetitions and work is 
generally equivalent although repetitions data exhibit a complex relationship between the 
magnitude of measurement and test-retest difference. Additionally, maximum height exhibits 
superior measurement agreement than both repetitions and work.    
The number, reliability, and agreement of our repetitions data are consistent with 
previously reported data for healthy participants (Svantesson et al., 1998, Moller et al., 2005, 
Hebert-Losier et al., 2009a) . For example, Moller et al.(Moller et al., 2005) reported test-retest 
means of 29.2-30.4, a non-significant mean difference of 1.2 (P = 0.71), ICC 0.84, CV 19.1%, 
and LoA 1.2 ± 16.5 repetitions for 10 healthy males. Our data are also very consistent with the 
performance of the healthy uninvolved limb of Achilles tendon rupture patients (Silbernagel et 
al., 2010, Olsson et al., 2011). For example, Olsson et al. (Olsson et al., 2011) employed the 
same measurement equipment and protocol as the current study and observed 35 ± 12 
repetitions, 3043 ± 1087 J of work, and 13.6 ± 2.5 cm maximum height for the uninvolved limb 
two years after conservatively managed Achilles tendon rupture.  
We have reported the six key testing parameters recommended by Hebert-Losier et al. 
(2009a) to aid standardisation of the HRET (i.e. ankle starting position (10° dorsiflexion); knee 
starting position (full extension); height (as high as possible); pace (30 raises·min-1); balance 
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support (finger tips); outcome measures (repetitions, work, maximum height); and test 
termination criteria (see Methods)). The linear encoder employed a minimum 1.0 cm threshold 
height that required attainment for the repetition to be counted. In addition, our data processing 
employed a further minimum height threshold of 5.0 cm that required attainment for a 
repetition to be counted and two consecutive repetitions <5.0 cm served as a test termination 
criteria. The 5.0 cm threshold was employed for consistency with previous research 
(Buchgraber and Passler, 1997, Moller et al., 2005) and to enable the comparison of our 
reproducibility data with previous studies (Moller et al., 2005). Despite almost a third of tests 
including repetitions <5.0 cm, the average number per affected test was only 1.8 with a 
maximum of five repetitions, and only 11.2% of tests were terminated on the basis of two 
consecutive <5.0 cm repetitions. Whilst we recommend use of the 1.0 cm threshold, the 5.0 cm 
threshold does not warrant recommendation.  In addition, we recommend video recording the 
HRET to identify movement artefacts at the end of testing, which occurred in 4.6% of our tests, 
and could lead to erroneous values, particularly for maximum height and work, if not identified.  
Our instruction to raise the heel as high as possible with each repetition is the most 
frequent height criterion reported in HRET research (Hebert-Losier et al., 2009a, Hebert-Losier 
et al., 2009b) and produced fatigue (42.3 % reduction in height) and task failure on average 
after 33.8 repetitions. Whilst acceptable reliability and agreement have been reported with 
alternative sub-maximal approaches, such as attaining a 5 cm height threshold on each 
repetition until task failure (Haber et al., 2004), we favour the current approach employing full 
range of movement at the ankle.   A further approach has been described in which the test is 
terminated when near maximum height can no longer be attained (Sman et al., 2014). This 
resulted in fewer repetitions (i.e. 23 ± 13.3) than the grand mean of 33.8 in our study and we 
argue that our protocol represents a better test of the endurance property of the muscle-tendon 
unit.   
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In addition to acceptable measurement error, recent evidence indicates that work and 
maximum height are more sensitive impairment measures than repetitions following ATR 
(Silbernagel et al., 2010, Olsson et al., 2011). For example, repetitions classified the percentage 
of patients having normal function at six and twelve months after ATR as 38% and 63%, 
respectively (Silbernagel et al., 2010). This compared to 9% and 23% for work and 6% and 
22% for maximum height at six and twelve months, respectively (Silbernagel et al., 2010). 
Work and maximum height (but not repetitions) also demonstrated significant positive 
associations at six months post ATR with the Achilles tendon Total Rupture Score (Silbernagel 
et al., 2010), a validated patient reported outcome measure (Nilsson-Helander et al., 2007). 
Work quantifies the positive vertical displacement of each repetition and therefore brings 
greater scientific rigour and accuracy to the quantification of muscle-tendon unit endurance 
performance. Maximum height appears reflective of reduced end-range strength (Mullaney et 
al., 2006) and increased tendon compliance and length (Silbernagel et al., 2012, Schepull et al., 
2007) following ATR. We therefore support the adoption of work and maximum height as 
objective outcome measures of muscle-tendon function in ATR research and clinical practice.   
 
Study Limitations 
The HRET described in this study is designed for use as an objective outcome measure in ATR 
rehabilitation. Our use of a healthy population limits the generalisability of our findings to a 
clinical population. Ideally, this study should be replicated in an ATR population. This would 
provide important information on reliability and agreement (particularly for the limb symmetry 
index) and enable the computation of the smallest detectable change for treatment evaluation. 
The use of a single trained outcome assessor (intrarater reliability) also limits the 
generalisability of our findings to interrater reliability. Nevertheless, we would anticipate 
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similar interrater reliability and agreement if the standardisation procedures described in this 
study are adhered to.       
 
Conclusion 
The reliability and measurement agreement of novel HRET work and maximum height 
outcome measures were at least equivalent to the traditional repetitions measure in healthy 
adults. Maximum height, in particular, demonstrated the best measurement agreement. These 
novel indices are supported by a stronger scientific rationale than repetitions and their use 
should add value to the ankle function assessment of ATR patients in research and clinical 
practice. 
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Table 1: Assessment of test-retest systematic bias for three heel-rise endurance test outcome measures in 38 healthy adults.  
 Test 
(mean ± SD) 
Retest 
(mean ± SD) 
Mean Difference  
(95% CI) 
P Value Effect Size  
(d) 
Repetitions  
Left (n) 
Right (n) 
LSI (%) 
  
Work  
Left (J) 
Right (J) 
LSI (%) 
  
Maximum Height  
Left (cm) 
Right (cm) 
LSI (%) 
 
 
32.6 ± 11.4 
34.7 ± 12.1 
94.6 ± 13.0 
 
 
2436 ± 908 
2583 ± 863 
94.5 ± 13.8 
 
 
13.5 ± 2.1 
13.6 ± 1.8 
99.8 ± 9.7 
 
32.6 ± 13.2 
35.1 ± 18.0 
95.9 ± 15.2 
 
 
2473 ± 1125 
2681 ± 1224 
93.6 ± 14.2 
 
 
13.7 ± 2.0 
13.8 ± 1.9 
99.3 ± 7.4 
 
0.0 (-2.8, 2.9) 
-0.4 (-3.7, 3.0) 
-1.3 (-6.7, 4.1) 
 
 
-37 (-211, 137) 
-98 (-314, 116) 
0.9 (-4.5, 6.2) 
 
 
-0.1 (-0.5, 0.2) 
-0.2 (-0.6, 0.2) 
0.4 (-3.2, 4.1) 
 
.985 
.826 
.624 
 
 
.666 
.358 
.745 
 
 
.448 
.276 
.812 
 
0.0 
-0.02 
-0.09 
 
 
-0.04 
-0.09 
-0.06 
 
 
-0.10 
-0.11 
0.06 
Abbreviations: LSI, limb symmetry index; 95% CI, 95% confidence interval. 
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Table 2: Intrarater test-retest reliability and agreement for three heel-rise endurance test outcome measures in 38 healthy adults. 
 ICC  
(95% CI) 
SEM  
(95% CI) 
CV  
(95% CI) 
MDC90 LoA  
(bias ± 95%) 
Percent LoA  
(bias ± 95%) 
Repetitions  
Left 
Right 
Pooled 
LSI 
 
Work  
Left 
Right 
Pooled 
LSI 
 
Maximum Height  
Left 
Right 
Pooled 
LSI 
 
0.75 (0.58, 0.86) 
0.78 (0.61, 0.88) 
0.77 (0.66, 0.85) 
0.33 (0.03, 0.74) 
 
 
0.87 (0.76, 0.93) 
0.81 (0.66, 0.90) 
0.84 (0.76, 0.89) 
0.34 (0.02, 0.59) 
 
 
0.87 (0.76, 0.93) 
0.83 (0.69, 0.91) 
0.85 (0.77, 0.90) 
0.17 (-0.15, 0.46) 
 
6.1 (5.0, 7.9) 
7.4 (6.0, 9.6) 
6.7 (5.8, 7.9) 
11.6 (9.5, 15.0) 
 
 
375 (305, 485) 
463 (377, 599) 
419 (361, 499) 
11.4 (9.3, 14.8) 
 
 
0.8 (0.6, 1.0) 
0.8 (0.6, 1.0) 
0.8 (0.7, 0.9) 
7.9 (6.4, 10.2) 
 
15.0 (12.1, 19.9) 
12.6 (10.1, 16.7) 
13.9 (11.9, 16.8) 
11.8 (9.5, 15.5) 
 
 
13.5 (10.9, 17.9) 
13.4 (10.8, 17.7) 
13.1 (11.2, 15.8) 
13.2 (10.6, 17.3) 
 
 
6.3 (5.1, 8.2) 
7.2 (5.9, 9.5) 
6.6 (5.7, 7.9) 
9.0 (7.3, 11.8)  
 
14.2 
16.9 
15.5 
27.0 
 
 
874 
1080 
977 
26.7 
 
 
1.8 
1.8 
1.8 
18.3 
 
0.0 ± 16.9* 
0.4 ± 20.1* 
0.2 ± 18.5* 
1.3 ± 32.1* 
 
 
37 ± 1038* 
99 ± 1283* 
68 ± 1161* 
-0.9 ± 31.7 
 
 
0.1 ± 2.1 
0.2 ± 2.1 
0.2 ± 2.1 
-0.4 ± 21.8 
 
-1.3 ± 37.9* 
-2.4 ± 37.0* 
-1.9 ± 37.2* 
1.0 ± 32.8 
 
 
-0.5 ± 33.5 
0.6 ± 36.4 
0.1 ± 34.8 
-1.1 ± 34.3 
 
 
1.2 ± 16.4 
1.4 ± 17.9 
1.3 ± 17.1 
-0.2 ± 22.1 
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Abbreviations: CV, percent coefficient of variation; ICC, intraclass correlation coefficient; LoA, limits of agreement; LSI, limb symmetry index; 
MDC90, minimal detectable change at the 90% confidence level; SEM, standard error of measurement; 95% CI, 95% confidence interval. 
*Indicates 
presence of heteroscedasticity in data (Pearson’s r, P < 0.05). 
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Figure Captions 
 
Figure 1: Participant performing the heel-rise endurance test on a 10° incline box, raising the 
heel as high as possible on each repetition, and with the linear encoder measurement device 
attached to the heel.  
 
Figure 2: Limits of agreement plots for (A) repetitions, (B) repetitions percent differences, (C) 
work, (D) work percent differences, (E) maximum height, and (F) maximum height percent 
differences. Plots illustrate individual difference in test-retest performance plotted against the 
mean of the individual’s two performances (A, C, E) or the difference expressed as a 
percentage of the mean of the individual’s two performances (B, D, F). Data represent the 
pooled data (i.e. left and right legs, n = 76) of the 38 participants with the solid line representing 
the mean difference and the dashed lines representing the upper and lower 95% limits of 
agreement.  
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Figure 1 
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Figure 2 
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